Back

Renal function and outcomes in subclinical atrial fibrillation: a prespecified analysis of the ARTESIA trial

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Epidemiology, prognosis, and outcomes in atrial fibrillation Oral Anticoagulation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Rohin Reddy

Duke University School of Medicine, Durham (United States of America)

6 More presentations in this session

Presentation thumbnail
Association between biological aging acceleration and adverse cardiovascular prognosis in atrial fibrillation patients: a multicenter real-world cohort study
Professor T. Liu (Tianjin, CN)
Abstract
Presentation thumbnail
Integrated care improves outcomes in multimorbid patients with atrial fibrillation: insights from the MIRACLE-AF trial
Doctor M. Li (Nanjing, CN)
Abstract
Presentation thumbnail
Predictions of adverse outcomes using different renal function estimation formulas in patients with atrial fibrillation receiving direct oral anticoagulants
Doctor T. Chao (Taipei, TW)
Abstract
Presentation thumbnail
Primary care physician continuity improve survival in patients with atrial fibrillation: a retrospective analysis of 15,000 patients with atrial fibrillation
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract
Presentation thumbnail
Early electrical cardioversion for early recurrent atrial tachyarrhythmia after pulmonary vein isolation in atrial fibrillation: a global real-world analysis
Miss L. Serio (L'Aquila, IT)
Abstract

Access the full session

Session thumbnail
Epidemiology, prognosis, and outcomes in atrial fibrillation

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of progressively impaired renal function on major adverse outcomes in european patients with atrial fibrillation: a report from the ESC EORP-AF long-term general registry
2 September 2019
thumbnail
Congress Presentation
Meta-analysis comparing impact of age, sex and renal function on the efficacy and safety of new oral anticoagulants vs. vitamin K antagonists for the treatment of acute venous thromboembolisms
28 August 2020
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
31 March 2025
thumbnail
Congress Presentation
Clinical implications of assessment of apixaban levels in elderly atrial fibrillation patients: J-ELD AF Registry sub-cohort analysis
31 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources